Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a newer build/version of the page. No changes to the study information are indicated.
    Difference
    0.0%
    Check dated 2026-05-16T08:42:38.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page’s revision/build label was incremented from v3.5.2 to v3.5.3, indicating an implementation update without changing the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-25T05:25:49.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T00:16:37.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T01:32:06.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T21:32:26.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. This is a minor metadata update to the page version.
    Difference
    0.0%
    Check dated 2026-02-12T01:39:51.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.